PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 19(6): 526-533
1999
© 1999 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bro, S
Right arrow Articles by Feldt-Rasmussen, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bro, S
Right arrow Articles by Feldt-Rasmussen, B
Peritoneal Dialysis International, Vol 19, Issue 6, 526-533
Copyright © 1999 by International Society for Peritoneal Dialysis


Clinical Trial

A prospective, randomized multicenter study comparing APD and CAPD treatment

S Bro, JB Bjorner, P Tofte-Jensen, S Klem, B Almtoft, H Danielsen, M Meincke, M Friedberg, and B Feldt-Rasmussen

Department of Nephrology, Rigshospitalet, Copenhagen, Denmark.

OBJECTIVE: The goals for maintenance dialysis treatment are to improve patient survival, reduce patient morbidity, and improve patient quality of life. This is the first randomized prospective study comparing automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) treatment with respect to quality of life and clinical outcomes in relation to therapy costs. DESIGN: A prospective, randomized multicenter study. SETTING: Three Danish CAPD units. PATIENTS: Thirty-four adequately dialyzed patients with high or high-average peritoneal transport characteristics were included in the study.Twenty-five patients completed the study. INTERVENTIONS: After randomization, 17 patients were allocated to APD treatment and 17 patients to CAPD treatment for a period of 6 months. Medical and biochemical parameters were evaluated at monthly controls in the CAPD units. Quality-of-life parameters were assessed at baseline and after 6 months by the self-administered short-form SF-36 generic health survey questionnaire supplemented with disease- and treatment-specific questions. Therapy costs were compared by evaluating dialysis-related expenses. MAIN OUTCOME MEASURES: Quality-of-life parameters, dialysis-related complications, dialysis-related expenses. RESULTS: The quality-of-life studies showed that significantly more time for work, family, and social activities was available to patients on APD compared to those on CAPD (p < 0.001). Although the difference was not significant, there was a tendency for less physical and emotional discomfort caused by dialysis fluid in the APD group. Sleep problems, on the other hand, tended to be more marked in the APD group. Any positive effect of APD compared to CAPD on dialysis-related hospital days or complication rates could not be confirmed. With larger patient samples, it is possible, however, that a significant difference might have been achieved. The running costs for APD treatment were US $75 per day and for CAPD treatment US $61 per day. CONCLUSION: If APD treatment can help to keep selected patients vocationally or socially active, paying the extra cost seems reasonable.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
D. W. Johnson, C. M. Hawley, S. P. McDonald, F. G. Brown, J. B. Rosman, K. J. Wiggins, K. M. Bannister, and S. V. Badve
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis
Nephrol. Dial. Transplant., February 1, 2010; (2010): gfp780v3 - gfp780.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. N. Davison, G. S. Jhangri, K. Jindal, and N. Pannu
Comparison of Volume Overload with Cycler-Assisted versus Continuous Ambulatory Peritoneal Dialysis
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1044 - 1050.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
W. M. Michels, M. Verduijn, E. W. Boeschoten, F. W. Dekker, R. T. Krediet, and for the NECOSAD Study Group
Similar Survival on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis in a Large Prospective Cohort
Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
V. Liakopoulos and N. Dombros
PATIENT SELECTION FOR AUTOMATED PERITONEAL DIALYSIS: FOR WHOM, WHEN?
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S102 - S107.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
R. Mehrotra
LONG-TERM OUTCOMES IN AUTOMATED PERITONEAL DIALYSIS: SIMILAR OR BETTER THAN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS?
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S111 - S114.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. J. Nessim and J. M. Bargman
Occurrence of peritonitis in APD versus CAPD: methodologic problems
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1769 - 1770.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. S. Rabindranath, J. Adams, T. Z. Ali, C. Daly, L. Vale, and A. M. MacLeod
Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2991 - 2998.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
P. K.-T. Li and K. M. Chow
MAXIMIZING THE SUCCESS OF PERITONEAL DIALYSIS IN HIGH TRANSPORTERS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S148 - S152.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
P. K.-T. Li, K. Y. Chung, and K. M. Chow
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IS BETTER THAN AUTOMATED PERITONEAL DIALYSIS AS FIRST-LINE TREATMENT IN RENAL REPLACEMENT THERAPY
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S153 - S157.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. F.M. Strippoli, A. Tong, D. Johnson, F. P. Schena, and J. C. Craig
Catheter-Related Interventions to Prevent Peritonitis in Peritoneal Dialysis: A Systematic Review of Randomized, Controlled Trials
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2735 - 2746.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Fusshoeller, M. Plail, B. Grabensee, and J. Plum
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2101 - 2106.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Fu{beta}holler, S. zur Nieden, B. Grabensee, and J. Plum
Peritoneal Fluid and Solute Transport: Influence of Treatment Time, Peritoneal Dialysis Modality, and Peritonitis Incidence
J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1055 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Basile and F. D. Padova
Comparison of peritonitis incidence in CAPD and automated peritoneal dialysis
Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1957 - 1958.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1999 by Multimed Inc.